We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MGNX market cap is 196.76M. The company's latest EPS is USD -0.1443 and P/E is -21.41.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.4M | 10.72M | 9.1M | 10.8M | 110.71M |
| Operating Income | -35.5M | -49.35M | -53.75M | -58.18M | 54.19M |
| Net Income | 17.55M | -46.07M | -52.19M | -55.66M | 56.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 64.19M | 104.88M | 77.45M | 151.94M | 58.75M |
| Operating Income | -177.19M | -131.06M | -202.8M | -121.42M | -168.24M |
| Net Income | -151.81M | -129.74M | -202.12M | -119.76M | -9.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 339.97M | 298.42M | 248.29M | 201.14M | 264.49M |
| Total Liabilities | 145.99M | 145.81M | 142.13M | 143.32M | 144.43M |
| Total Equity | 193.98M | 152.61M | 106.15M | 57.82M | 120.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 312.5M | 378.74M | 335.25M | 280.47M | 298.42M |
| Total Liabilities | 81.87M | 82.86M | 95.63M | 138.46M | 145.81M |
| Total Equity | 230.63M | 295.88M | 239.62M | 142.01M | 152.61M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.17M | -78.21M | -45.64M | -90.13M | -29.97M |
| Investing | -118.91M | -80.08M | 24.79M | 72.23M | 107.83M |
| Financing | 150.09M | 150.36M | 248k | 873k | 805k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -134.27M | -111.9M | -143.83M | -86.96M | -78.21M |
| Investing | -79.36M | -7.79M | -36.61M | 70.72M | -80.08M |
| Financing | 119.97M | 174.34M | 122.78M | 1.66M | 150.36M |
| Market Cap | 196.76M |
| Price to Earnings Ratio | -21.41 |
| Price to Sales Ratio | 3.3 |
| Price to Cash Ratio | 1.92 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 62.76M |
| Average Volume (1 week) | 500.63k |
| Average Volume (1 Month) | 475.22k |
| 52 Week Change | -70.17% |
| 52 Week High | 21.88 |
| 52 Week Low | 2.9511 |
| Spread (Intraday) | 0.01 (0.32%) |
| Company Name | MacroGenics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.macrogenics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
